China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Gemcitabine and stereotactic radiotherapy to augment immunotherapy for osteosarcoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135581
Registration Time: 2026/10/30
Type: Interventional study
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349796
Published by HT Digital Content Services with permission from Health Daily Digest....